EU Logo The projects GENE2SKIN, under the Grant Agreement Number 692221 and FoReCaST, under the Grant Agreement Number 668983 have received funding from the European Union's Horizon 2020 Research and Innovation programme.

The 2017 GENE2SKIN Winter School Program

Download Program108.33 KB
Download Scientific Program906.5 KB


Download Program99.3 KB
Download Scientific Program217.62 KB

The 2017 GENE2SKIN Winter School

“Skin Tissue disorders and advanced TE/genetic-based treatment strategies”

Fundação Dr. António Cupertino de Miranda, Porto, Portugal
13-15 NOVEMBER 2017

The 2017 GENE2SKIN Winter School is being organized in the scope of the European Horizon 2020 Twinning project GENE2SKIN: Roadmap for advanced genetic engineering-based skin therapies ( It aims at providing young researchers a learning experience regarding the molecular mechanisms involved in skin physiology and pathophysiology and potential gene-based therapies for the treatment of several skin diseases.




Fernando Larcher, University Carlos III de Madrid, Spain

Teresa Odorisio, IDI-IRCCS, Italy

Rebecca Lee, University of Manchester, UK



Alberto Piaggesi, University of Pisa, Italy

Alberto Mota, University of Porto, Portugal

Michael Kasperkiewicz, University of Lübeck, Germany



Carla Couto, President of DEBRA PT, Portugal

Miguel Oliveira, Portuguese Society

of Podiatry, Portugal



GenoSkin, France

Aurealis Pharma, Switzerland/ Finland

Organogenesis Inc, USA



Diabetic Wounds     Melanoma     Squamous Carcinoma      Genodermatosis      Wound Healing




Meeting Chairs


Fundação Dr. António Cupertino de Miranda
Porto, Portugal
15-17 NOVEMBER 2017

TERM STEM comprises a series of annual conferences organized by 3B’s Research Group and supported by the Northern Portugal Regional Development Authority. This Conference Series intends to provide and establish an international forum for the presentation and discussion of frontier research in the fields of Tissue Engineering, Regenerative Medicine and Stem Cells. We are very excited by the program of the 2017 edition of TERMSTEM that will join a strong slate of world scientific leaders to showcase and discuss the latest research on the interplay between biomaterial structures and surfaces, morphogens and stem cells to modulate tissue regeneration. This edition will also feature foundational contributions in the emergent topic of organs on a chip and microfluidic supporting devices and its current industrial perspectives.



Antoniac Iulian - Polytechnic University of Bucharest, Romania

Yasuhiko Tabata - Kyoto University, Japan

Clemens van Blitterswijk - Maastricht University, The Netherlands

Gilson Khang - Chonbuk National University, Korea

Utkan Demirci - Stanford University, US

Claudio Migliaresi - University of Trento, Italy

Antonella Motta - University of Trento, Italy

Willian Wagner - University of Pittsburgh, US

Julio San Roman – CSIC, Spain

James Yoo - Wake Forest Institute for Regenerative Medicine, US

Kevin Healy - University of California at Berkeley, US

Heinz Redl - Ludwig Boltzmann Institute, Austria





Meeting Chairs



The majority of the in vitro models only involve a single tumour cell population, which represents a small fraction of the tumour development and integrative cell network. Therefore, a new dimension in cancer research has to be developed: the 3D microenvironment. Thus, the FoReCaST project intend to create in vitro 3D cancer study models, which will copycat the complexity and hierarchically organization of natural ECM of tumour cells found in vivo. In this context, 3B’s-UMINHO will strategically use the knowledge gained during the last ~20years in the fields of biomaterials sciences and tissue engineering, and five new complementary research topics are being implemented to consolidate this new research topic within the following topics (Fig.1):

  • RL1 - Metabolic glycoengineering for tumour imaging;
  • RL2 - Bioinformatics;
  • RL3 - Cell engineering;
  • RL4 - Nanotechnologies
  • RL5 - Cell signalling


Figure 1:Integration of ERA Chairs research domain in the scientific strategy of 3B’s-UMINHO towards the consolidation of cancer research.



Ranieri Cancedda - University of Genoa, Italy

Suman Chakraborty - Indian Institute of Technology Kharagpur, India

Jean-Olivier Durand – University of Montpellier, France

Josep Samitier - Institute for Bioengineering of Catalonia, Spain

Pietro Lio - University of Cambridge, UK

Paolo A. Netti - Italian Institute of Technology, Italy

Philip Lazarovici - Hebrew University of Jerusalem, Israel

Luca Primo - University of Torino, Italy

Lorenz Meinel - University of Würzburg, Germany


Meeting Chairs



Organized by
3B’s Research Group, University of Minho, Braga, Portugal


A member of PT Government Associate Laboratory ICVS/3B’s


Gene2Skin and Term Stem / ForeCast 2017,
3B's Research Group,
Department of Polymer Engineering,
University of Minho,

Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine,

Avepark - Parque de Ciência e Tecnologia
Zona Industrial da Gandra
4805-017 Barco GMR - Portugal

Tel: +351 253 510 900
Fax: +351 253 510 909
URL: | |